Plain-English translation of NCT07491042 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a medication called to see if it can help people with end-stage kidney disease who use peritoneal dialysis (a type of home-based kidney treatment). Researchers believe the medication may help your dialysis work better by improving fluid removal and protecting the lining of your abdomen. The study will last six months and involve about 38 patients.
Peritoneal dialysis can become less effective over time because the membrane in your abdomen can become damaged and scarred. This medication has shown promise in other kidney disease studies, and researchers think it might help prevent that damage and make dialysis more effective—even for patients without diabetes.
You likely qualify if…
You likely don't qualify if…
You would take the study medication daily for six months while continuing your regular peritoneal dialysis treatment. During this time, researchers will track how well your dialysis is working, measure your fluid removal, check your blood sugar levels, and monitor markers of inflammation. You'll have regular clinic visits to provide blood and urine samples so doctors can see how the medication is affecting your kidney function.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Oman
Sponsor
Oman Ministry of Health
Enrollment target
~38 participants
Started
April 2026
Primary completion
September 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
13 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jehad Badawi B AL LAHAM
Oman Ministry of Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.